bcbs fep glp 1 coverage GLP-1 for obesity treatment in 13 US states' Medicaid programs Rising Costs Lead Insurers to
Description
Medication alone wont solve the obesity crisis Despite the excitement and potential of these drugs, the WHO cautioned that obesity treatment still must be paired with healthy diets and physical activity
In 2021, FDA approved Novos Wegovy for chronic weight management
Hospital inpatients typically receive variable rate intravenous insulin infusions during major surgery, transitioning to subcutaneous insulin regimens post-operatively until oral intake resumes and Mounjaro can be safely restarted, as outlined in CPOC guidance
It is about blood pressure, blood sugar, cholesterol, fatty liver, sleep apnea, mobility, cardiovascular risk, and quality of life
In a February 2026 Zogby survey of 2,000 adults, users of compounded GLP-1 medications reported satisfaction and perceived effectiveness slightly higher than those using FDA-approved versions
doi: 10.3803/EnM.2021.1293 98 LeeY-SParkM-SChoungJ-SKimS-SOhH-HChoiC-Set al
